Back to Journals » Drug Design, Development and Therapy » Volume 15

Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP®) Biosimilar, to Those of NESP® After a Single Subcutaneous or Intravenous Administration to Healthy Subjects

Total article views   HTML views PDF downloads Totals
5,237 Dovepress* 4,708+ 464 5,172
PubMed Central* 529 171 700
Totals 5,237 635 5,872
*Since 28 April 2021

View citations on PubMed Central and Google Scholar